We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+4.99%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$110B
AUM Growth
+$11.3B
(+11%)
Cap. Flow
+$8.89B
Cap. Flow
% of AUM
8.09%
Top 10 Holdings %
Top 10 Hldgs %
35.27%
Holding
3,643
New
809
Increased
972
Reduced
1,047
Closed
744
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.35B |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$2.85B |
| 3 |
Eli Lilly
LLY
|
+$999M |
| 4 |
Coca-Cola
KO
|
+$685M |
| 5 |
Broadcom
AVGO
|
+$616M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.38B |
| 2 |
Apple
AAPL
|
+$1.12B |
| 3 |
Netflix
NFLX
|
+$678M |
| 4 |
Boston Scientific
BSX
|
+$671M |
| 5 |
Cencora
COR
|
+$627M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.19% |
| 2 | Consumer Discretionary | 12.77% |
| 3 | Healthcare | 10.45% |
| 4 | Financials | 7.74% |
| 5 | Communication Services | 5.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Live Nation Entertainment
LYV
$42.1B
| $20.9M | 0.02% |
146,541
+140,504
| +2,327% | +$20.2M |
|
602
Core Scientific
CORZ
$6.75B
| $20.9M | 0.02% |
1,433,481
-22,505
| -2% | -$392K |
|
603
WIX.com
WIX
$2.52B
| $20.8M | 0.02% |
200,000
| – | – |
|
604
Intuitive Machines
LUNR
$2.63B
| $20.5M | 0.02% |
1,260,459
+1,058,376
| +524% | +$12.3M |
|
605
Praxis Precision Medicines
PRAX
$10.1B
| $20.4M | 0.02% |
69,242
+1,101
| +2% | +$205K |
|
606
Ionis Pharmaceuticals
IONS
$9.4B
| $20.3M | 0.02% |
256,933
-701,896
| -73% | -$52.9M |
|
|
ESPR
607
DELISTED
Esperion Therapeutics
ESPR
| $20.2M | 0.02% |
5,471,611
+2,950,172
| +117% | +$9.53M |
|
608
Bunge Global
BG
$20.8B
| $20.2M | 0.02% |
226,382
-221,151
| -49% | -$20.4M |
|
609
Lockheed Martin
LMT
$136B
| $20.2M | 0.02% |
41,678
-58,422
| -58% | -$28M |
|
610
Digital Realty Trust
DLR
$71.7B
| $20M | 0.02% |
129,428
-66,983
| -34% | -$11M |
|
|
GOOS
611
Canada Goose Holdings
GOOS
$856M
| $20M | 0.02% |
1,540,714
+877,987
| +132% | +$11.7M |
|
612
Healthpeak Properties
DOC
$14.8B
| $19.9M | 0.02% |
1,240,091
+483,563
| +64% | +$8.53M |
|
613
Silicon Laboratories
SLAB
$7.23B
| $19.9M | 0.02% |
152,334
-46,969
| -24% | -$6.17M |
|
614
Samsara
IOT
$23.8B
| $19.8M | 0.02% |
559,629
+164,762
| +42% | +$6.38M |
|
615
Celanese
CE
$4.82B
| $19.7M | 0.02% |
466,036
-80,288
| -15% | -$3.27M |
|
616
Copa Holdings
CPA
$5.8B
| $19.7M | 0.02% |
163,349
+41,891
| +34% | +$5.12M |
|
617
Webster Financial
WBS
$12.8B
| $19.6M | 0.02% |
311,781
-79,431
| -20% | -$4.72M |
|
618
Sensient Technologies
SXT
$5.53B
| $19.4M | 0.02% |
206,863
-113,637
| -35% | -$10.7M |
|
619
Alcon
ALC
$35B
| $19.4M | 0.02% |
243,035
-463,197
| -66% | -$35.7M |
|
620
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
| $19.3M | 0.02% |
+32,062
| New | +$19.2M |
|
621
AXIS Capital
AXS
$7.55B
| $19.3M | 0.02% |
180,582
+18,616
| +11% | +$1.85M |
|
|
TIGR
622
UP Fintech Holding
TIGR
$861M
| $19.3M | 0.02% |
2,019,197
+1,135,587
| +129% | +$10.8M |
|
623
Tandem Diabetes Care
TNDM
$1.56B
| $19.2M | 0.02% |
+875,531
| New | +$15.8M |
|
624
AST SpaceMobile
ASTS
$21.5B
| $19.2M | 0.02% |
264,591
+242,311
| +1,088% | +$17.3M |
|
625
Illumina
ILMN
$28.4B
| $19.2M | 0.02% |
+146,478
| New | +$17.2M |
|
Similar funds
Marshall Wace's Q4 2025 Portfolio in Review
As of Q4 2025, Marshall Wace held 3,643 positions worth $110B, up 11% from $98.6B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Marshall Wace deployed $8.89B of net new capital in Q4 2025, opening 809 new positions and adding to 972 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $1.38B trimmed.
- Marshall Wace's largest Q4 2025 buy was Vanguard S&P 500 ETF: 4,580,704 shares worth $2.87B.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $3.35B increase.
- Marshall Wace's biggest Q4 2025 reduction was Microsoft, cutting an estimated $1.38B.
- Marshall Wace fully exited Ares Management in Q4 2025, selling an estimated $146M.
- Marshall Wace's ten largest holdings make up 35% of its $110B portfolio in Q4 2025.
- Marshall Wace opened 809 new positions and closed 744 in Q4 2025.
- Marshall Wace's portfolio value rose 11% quarter-over-quarter to $110B.
Based on Marshall Wace's 13F filing for Q4 2025, filed 13 Feb 2026.